Clinical Trials on Uveal Melanoma in Germany
Total 325 results
-
Hasumi International Research FoundationActive, not recruitingMelanoma, Uveal MetastaticGermany
-
Prof. Dr. med. Max. E. ScheulenClinAssess GmbHUnknownUveal MelanomaGermany
-
Charite University, Berlin, GermanyRecruiting
-
Array Biopharma, now a wholly owned subsidiary...TerminatedUveal MelanomaUnited States, France, Germany, Netherlands, Spain, United Kingdom
-
University Hospital ErlangenUniversity Hospital, Essen; University Hospital Tuebingen; Universitätsklinikum... and other collaboratorsActive, not recruiting
-
Novartis PharmaceuticalsRecruitingMetastatic Uveal MelanomaUnited States, Australia, France, Netherlands, Switzerland, Germany, Spain
-
Columbia UniversityRecruitingUveal MelanomaUnited States, Australia, Canada, Germany, United Kingdom
-
Immunocore LtdCompletedUveal MelanomaSpain, United States, Germany, Canada, United Kingdom
-
AstraZenecaCompletedUveal Melanoma | MetastaticUnited States, Czech Republic, Spain, United Kingdom, Germany, Canada, Israel, Netherlands, Belgium, France, Finland
-
Charite University, Berlin, GermanyUnknownUveal Melanoma | Exudative Retinal DetachmentGermany
-
IDEAYA BiosciencesRecruitingMetastatic Uveal MelanomaUnited States, Canada, Israel, Spain, Australia, Germany, France, Italy, United Kingdom, Netherlands, Belgium, Poland, Switzerland
-
Immunocore LtdActive, not recruitingUveal MelanomaUnited States, Canada, United Kingdom, Spain, France, Germany, Poland, Australia, Belgium, Italy, Netherlands, Russian Federation, Switzerland, Ukraine
-
IDEAYA BiosciencesRecruitingUveal MelanomaUnited States, Australia, Canada, Netherlands, Italy, France, Germany, United Kingdom
-
Bristol-Myers SquibbCompleted
-
National Center for Tumor Diseases, HeidelbergUniversity Hospital HeidelbergCompleted
-
University Hospital TuebingenGerman Research FoundationCompleted
-
Charite University, Berlin, GermanyUnknown
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
University Hospital TuebingenCompleted
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Charite University, Berlin, GermanyUnknown
-
University of RegensburgUnknown
-
University of RegensburgClinAssess GmbHUnknown
-
University Hospital TuebingenUnknownMalignant Melanoma Stage IVGermany
-
Krankenhaus NordwestTerminatedChemo-refractory MelanomaGermany
-
Ruhr University of BochumCompleted
-
Fachklinik Hornheide an der Universität MünsterWestfälische Wilhelms-Universität Münster; Deutsche RentenversicherungCompletedQuality of Life | Work Ability | Malignant Melanoma of SkinGermany
-
University Hospital ErlangenCompleted
-
Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum...Unknown
-
European Organisation for Research and Treatment...Terminated
-
University Hospital ErlangenCompleted
-
University Hospital ErlangenCompleted
-
University Hospital MuensterUnknown
-
Philogen S.p.A.Active, not recruiting
-
University Hospital TuebingenTerminatedMetastatic Melanoma (Carrying BRAF V600 Mutation)Germany
-
University Hospital FreiburgUniversitätsklinikum Köln; Essex Pharma GmbHUnknownMalignant MelanomaGermany
-
4SC AGCompletedMalignant MelanomaGermany, Italy
-
Philogen S.p.A.CompletedMalignant MelanomaAustria, Germany
-
University Hospital TuebingenCompletedLocoregional Metastases in Malignant Melanoma Stages IIIB/CGermany
-
Azienda Ospedaliera di PerugiaNot yet recruitingAdvanced Melanoma | Early MelanomaItaly, Sweden, France, Germany, Netherlands, Poland, Spain
-
Ruhr University of BochumCompletedCutaneous Malignant MelanomaGermany
-
Novo Nordisk A/STerminatedCancer | Malignant MelanomaGermany
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsBelgium, Spain, Germany, Netherlands, Finland
-
Prof. Dr. med. Dirk SchadendorfBoehringer Ingelheim; medac GmbH; Alcedis GmbHCompletedCutaneous Malignant MelanomaGermany
-
Dermatologic Cooperative Oncology GroupUnknownTherapy | Adjuvant | Stage III Malignant Melanoma | Interferon AlphaGermany
-
University Hospital TuebingenTerminatedMalignant MelanomaGermany, France
-
Cytos Biotechnology AGCompleted
-
Miltenyi Biomedicine GmbHDLR German Aerospace CenterTerminated
-
Bristol-Myers SquibbActive, not recruiting
-
Prof. Dr. med. Dirk SchadendorfTerminatedMalignant MelanomaGermany